However, all tumor samples were positive for phospho-4E-binding protein 1 (p4E-BP1; Figure 4C) and phospho-ribosomal protein S6 (pS6RP; Figure 4F), which are targets of the mammalian target of rapamycin (mTOR) pathway [22]. The gene discussed is RPS6; the disease is neoplasm.